
51 - 200 employees
Founded 2015
🏥 Healthcare
🧬 Biotechnology
⚕️ Healthcare Insurance
Healthcare • Biotechnology • Healthcare Insurance
ProKidney Corp. is a late clinical-stage biotechnology company focused on pioneering cell therapy as a treatment for Chronic Kidney Disease (CKD). Their innovative approach aims to transform the therapeutic options available for advanced CKD by preserving kidney function, potentially delaying or eliminating the need for dialysis. With a focus on an area of high unmet medical need, ProKidney's cell therapy candidate, rilparencel, is at the forefront of clinical studies to provide alternative solutions for patients with limited treatment options. The company is committed to advancing its pipeline through clinical and regulatory developments and actively participates in healthcare conferences to bring attention to its groundbreaking work in CKD treatment.
🔥 4 hours ago
Strategic leader for global clinical development at ProKidney overseeing Phase I-III trials and ensuring compliance. Collaborating with external stakeholders and internal teams to guide clinical development.
🕒 June 25
Regulatory Publishing Consultant supporting the preparation and publishing of regulatory documents at ProKidney. Collaborating cross-functionally with Regulatory Affairs, Medical Writing, and Quality stakeholders.